DF

Dian Badran Fcca

Head Of Commercial Finance at mdgroup

Dian Badran, FCCA, has extensive work experience in various finance roles. They began their career at Towergate JBI International Insurance Brokers in 2012 as a Management Accountant. After that, they worked at Getronics as a Finance Manager / P2P Treasury Specialist from 2014 to 2015. They then joined Mobile Phones Direct, where they served as a Management Accountant from 2015 to 2017 and later as a Financial Controller from 2017 to 2019. In 2019, they moved to ELM Group (RLHA/ELM) as a Financial Controller before joining mdgroup in 2019. At mdgroup, they initially worked as a Finance Business Partner from 2019 to 2021 and currently hold the position of Head of Commercial Finance.

Dian Badran FCCA attended Kaplan from 2011 to 2017. However, the information provided does not specify the degree name or field of study pursued during this time.

Location

Reading, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


mdgroup

We’re on a mission to make life better for patients taking part in clinical trials around the world, and their caregivers. Our solutions focus on the four key elements of a successful clinical trial: recruitment, engagement, retention and trial outcomes. Combining our in-house technology platforms with 24/7 truly personalised patient care, we focus on creating remarkable patient experiences at every stage of the clinical journey. ‘Remarkable’ means going above and beyond to support patients in a way that works best for them and their lives. Whether that’s facilitating clinical trial participation in their own homes, supporting them to travel safely to and from study sites, or using technology to manage everything from expense reimbursement to telehealth, we work with our partners to support the protocol design that meets their patient’s needs. Understanding the complexities of the patient journey is paramount to advancing medicine, and exploring digital technology that enables better trial outcomes has never been more important. This all starts with putting patients first in clinical research. When you partner with us, your patients receive a truly remarkable service and your trial outcomes are better.


Employees

51-200

Links